About IDbyDNA
IDbyDNA is a company based in Salt Lake City (United States) founded in 2014. IDbyDNA has raised $29 million across 2 funding rounds from investors including ARUP Laboratories, Artis Ventures and Genesys Capital. IDbyDNA operates in a competitive market with competitors including Human Longevity, Helix, Benchling, Genuity Science and Inpharmatica, among others.
- Headquarter Salt Lake City, United States
-
Sectors
HealthcareTechnology
-
Phone
Locked
-
Website
Locked
-
Social
Locked
-
Annual Revenue
Not available
-
Net Profit
Not available
-
EBITDA
Not available
-
Total Equity Funding
$29 M (USD)
in 2 rounds
-
Latest Funding Round
$20 M (USD), Series B
Jan 29, 2020
-
Investors
ARUP Laboratories
& 3 more
-
Employee Count
Not available
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
People of IDbyDNA
Unlock access to complete
Unlock access to complete
Software Development Team
249 people
Senior Team
70 people
Leadership Team
67 people
Sales and Marketing
44 people
Staff Team
42 people
Product Management Team
36 people
Finance and Accounting
31 people
Data Analysis and Operations Team
25 people
Unlock access to complete
Funding Insights of IDbyDNA
IDbyDNA has successfully raised a total of $29M across 2 strategic funding rounds. The most recent funding activity was a Series B round of $20 million completed in January 2020. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
Investors in IDbyDNA
IDbyDNA has secured backing from 4 investors, including venture fund and institutional investors. Prominent investors backing the company include ARUP Laboratories, Artis Ventures and Genesys Capital.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Early-stage startups are invested in by Artis Ventures.
|
Locked | Locked | Locked | |
|
Early-stage life sciences companies are supported through venture capital investments.
|
Locked | Locked | Locked | |
|
Early-stage startups are invested in by sector-agnostic VC firm.
|
Locked | Locked | Locked |
Investor details for IDbyDNA
Investor domains, locations, round participation, and complete history require an active premium plan.
- Investor domains
- Investor locations
- Funding rounds
- Participation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by IDbyDNA
Investment portfolio details for IDbyDNA
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
Financial Statements - IDbyDNA
Detailed financials for IDbyDNA
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Idbydna Comparisons
Peer comparison for IDbyDNA
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of IDbyDNA
IDbyDNA operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Human Longevity, Helix, Benchling, Genuity Science and Inpharmatica, among others.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| Locked | Locked | Locked |
Genomics data and cell therapy-based diagnostic and therapeutic solutions
|
|
| Locked | Locked | Locked |
Genomic database for clinical research is provided.
|
|
| Locked | Locked | Locked |
Cloud-based bioinformatics platform is offered for biotech research.
|
|
| Locked | Locked | Locked |
AI-based omics data analysis solutions are provided to researchers.
|
|
| Locked | Locked | Locked |
Developer of predictive informatics based platform for drug discovery
|
|
| Locked | Locked | Locked |
Bioinformatics platform is provided for biomarkers and drug discovery.
|
Detailed competitors of IDbyDNA
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Idbydna
Complete news archive for IDbyDNA
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about IDbyDNA
IDbyDNA was founded in 2014 and raised its 1st funding round 2 years after it was founded.
IDbyDNA is headquartered in Salt Lake City, United States. It is registered at Salt Lake City, Utah, United States.
IDbyDNA is a funded company, having raised a total of $29M across 2 funding rounds to date.
IDbyDNA was founded in 2014 in Salt Lake City, United States, operating within the biotechnology sector focused on genomic analysis. Taxonomer, its core platform, is utilized for metagenomic sequencing of next-generation data to detect pathogens. Curated databases covering bacterial, viral, and fungal taxa are employed for taxonomic classification based on nucleic acids or proteins. Real-time analysis of large datasets is supported for clinical and research applications.
IDbyDNA's top competitors include Helix, Human Longevity and Benchling.
IDbyDNA has 4 investors. Key investors include ARUP Laboratories, Artis Ventures, Genesys Capital, and Abstract Ventures.